Treating epilepsy in the elderly - Safety considerations

被引:40
作者
Arroyo, S
Kramer, G
机构
[1] Hosp Clin Barcelona, Unidad Epilepsia, E-08036 Barcelona, Spain
[2] Swiss Epilepsy Ctr, Zurich, Switzerland
关键词
D O I
10.2165/00002018-200124130-00006
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The incidence of epilepsy increases with advancing age. Epilepsy in the elderly has different aetiologies from that in younger populations, cerebrovascular disease being the most common condition associated with seizures. Partial seizures are the predominant seizure type in older patients. A diagnosis of epilepsy in the elderly is based mainly on the history and is frequently delayed. In addition, seizure imitators are especially frequent. In many cases ancillary tests for diagnosis may show normal age-related variants, sometimes making results difficult to interpret. Treating epilepsy in the elderly is problematic due to a number of issues that relate to age and comorbidity. The physical changes associated with increasing age frequently lead to changes in the pharmacokinetics of many anticonvulsants. The treatment of epilepsy in the elderly is also complicated by the existence of other diseases that might affect the metabolism or excretion of anticonvulsants and the presence of concomitant medications that might interact with them. Moreover, specific trials of anticonvulsants in the aged population are scarce. General guidelines for treatment include starting at lower doses, slowing the titration schedule, individualising the choice or anticonvulsant to the characteristics of the patient, avoiding anticonvulsants with important cognitive or sedative adverse effects, and where possible, treating with monotherapy.
引用
收藏
页码:991 / 1015
页数:25
相关论文
共 223 条
[1]  
Abou-Khalil B, 2000, EPILEPSIA, V41, pS72
[2]   Tiagabine - A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy [J].
Adkins, JC ;
Noble, S .
DRUGS, 1998, 55 (03) :437-460
[3]   A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures [J].
Aldenkamp, AP ;
Baker, G ;
Mulder, OG ;
Chadwick, D ;
Cooper, P ;
Doelman, J ;
Duncan, R ;
Gassmann-Mayer, C ;
de Haan, GJ ;
Hughson, C ;
Hulsman, J ;
Overweg, J ;
Pledger, G ;
Rentmeester, TW ;
Riaz, H ;
Wroe, S .
EPILEPSIA, 2000, 41 (09) :1167-1178
[4]   Diagnostic yield and development of a neurocardiovascular investigation unit for older adults in a district hospital [J].
Allcock, LM ;
O'Shea, D .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2000, 55 (08) :M458-M462
[5]   Revised Winter-Tozer equation for normalized phenytoin concentrations in trauma and elderly patients with hypoalbuminemia [J].
Anderson, GD ;
Pak, C ;
Doane, KW ;
Griffy, KG ;
Temkin, NR ;
Wilensky, AJ ;
Winn, HR .
ANNALS OF PHARMACOTHERAPY, 1997, 31 (03) :279-284
[6]   INCIDENCE OF ACUTE SYMPTOMATIC SEIZURES IN ROCHESTER, MINNESOTA, 1935-1984 [J].
ANNEGERS, JF ;
HAUSER, WA ;
LEE, JRJ ;
ROCCA, WA .
EPILEPSIA, 1995, 36 (04) :327-333
[7]   Predictive factors of early seizures after acute cerebrovascular disease [J].
Arboix, A ;
GarciaEroles, L ;
Massons, JB ;
Oliveres, M ;
Comes, E .
STROKE, 1997, 28 (08) :1590-1594
[8]   Reversible parkinsonism and cognitive impairment with chronic valproate use [J].
Armon, C ;
Shin, C ;
Miller, P ;
Carwile, S ;
Brown, E ;
Edinger, JD ;
Paul, RG .
NEUROLOGY, 1996, 47 (03) :626-635
[9]   MODERATE NON-KETOTIC HYPERGLYCEMIA - CAUSE OF FOCAL EPILEPSY - REPORT OF 2 CASES AND REVIEW OF LITERATURE [J].
ASKENASY, JJ ;
STREIFLER, M ;
CARASSO, R .
EUROPEAN NEUROLOGY, 1977, 16 (1-6) :51-61
[10]   Current issues in the management of epilepsy: The impact of frequent seizures on cost of illness, quality of life, and mortality [J].
Baker, GA ;
Nashef, L ;
vanHout, BA .
EPILEPSIA, 1997, 38 :S1-S8